Study details
Enrolling now
Assess Fibrin in Brains With AD/ADRD
Massachusetts General Hospital
NCT IDNCT05336695ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1/2
Target enrollment
30
Study length
about 4.5 years
Ages
55–90
Locations
1 site in MA
What this study is about
This trial is testing a new imaging test called 64Cu-FBP8-PET to measure fibrin levels in the brains of people with Alzheimer's Disease or Dementia of Alzheimer Type. The goal is to see if there are differences in fibrin levels based on how far along the disease is.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take 64Cu-FBP8
- 2.Undergo PET/MR Imaging
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Procedures
imaging
Devices
diagnostic
Body systems
Neurology